Latest News

© Dr_Microbe - © Dr_Microbe - stock.adobe.com
Phase III Trial Data Show Roche’s Xofluza Significantly Reduces Flu Transmission

April 25th 2025

Xofluza (baloxavir marboxil) met its primary endpoint in the CENTERSTONE trial, reducing the odds of untreated household members contracting influenza virus by 32%.

Credit: Andrey Popov | stock.adobe.com
Phase II Advance-HTN Trial Shows Lorundrostat Significantly Lowers Blood Pressure in Treatment-Resistant Hypertension

April 25th 2025

The Importance of Clinical Trial Oversight when Outsourcing
The Importance of Clinical Trial Oversight when Outsourcing

April 25th 2025

Credit: Thipphaphone | stock.adobe.com
Phase III ASPEN Trial Shows Brensocatib Reduces Exacerbations, Lung Function Decline in Bronchiectasis

April 24th 2025

Embracing Risk-Based Approaches with Clinical Trial Oversight
Embracing Risk-Based Approaches with Clinical Trial Oversight

April 24th 2025

Applied Clinical Trials April 2025

Check out the latest features and columns!

Check out the latest features and columns!

Conference Coverage

View All
© Egor - © Egor - stock.adobe.com
Notable Discussions from SCOPE 2025: Aiming to Calculate, Accommodate, and Innovate for Enhanced Drug Development

March 11th 2025

Set the Course for a More Engaging & Productive Patient & Clinical Trial Site Journey
Set the Course for a More Engaging & Productive Patient & Clinical Trial Site Journey

February 26th 2025

SCOPE Summit 2025: Shakthi Kumar Talks Real-World Data Use in Clinical Development
SCOPE Summit 2025: Shakthi Kumar Talks Real-World Data Use in Clinical Development

February 24th 2025

SCOPE Summit 2025: Graham Clark on Ensuring Data Consitency Amid the Rise of Real-World Evidence
SCOPE Summit 2025: Graham Clark on Ensuring Data Consitency Amid the Rise of Real-World Evidence

February 21st 2025

Latest Videos
Podcasts

All News

© 2025 MJH Life Sciences

All rights reserved.